How Neurocrine Biosciences Crushed It in Q2

Neurocrine Biosciences' (NASDAQ:NBIX) 30% plunge earlier this year during the coronavirus-fueled market meltdown is practically all but forgotten now. The stock was up around 15% as of the market close on Monday.